Skyrizi 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FP8RC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,626
Award facts
- Contract value 100% obligated
- $53,626.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,626.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 15, 2026, for the supply of SKYRIZI 150 mg/mL syringes. The contract, designated as a non-set-aside competitive award, has an ultimate completion date of January 16, 2026, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialized pharmaceutical products across multiple therapeutic domains through competitively awarded, firm fixed-price arrangements with DLA. This order for SKYRIZI, a specialty pharmaceutical used for dermatological conditions, exemplifies the company's role in fulfilling essential medical supply requirements for the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FP8RC?
SPE2DR26FP8RC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FP8RC worth?
The government has obligated $53,626 on SPE2DR26FP8RC.
Is contract SPE2DR26FP8RC an order under another contract?
Yes. SPE2DR26FP8RC is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8RC competed?
The extent of competition for SPE2DR26FP8RC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award